Key facts
- Care Access’s last known valuation is $50.0M (Sep 2025).
- It has raised $80K; the latest was Equity Crowdfunding ($120K) in Nov 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Care Access
- ·The full record, as it builds
Funding rounds
No funding rounds for Care Access are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Care Access
Developer of clinical research site network services designed to expand access to clinical trials and support the development of new medical treatments. The company's platform offers health screenings, decentralized and hybrid trial models, participant recruitment, and operational support, enabling pharmaceutical sponsors, healthcare providers, and patients to participate in and conduct clinical research more efficiently and with broader inclusion by addressing common barriers to trial access and diversity.
- Sector
- Healthcare
- HQ
- Washington, DC, United States
- Founded
- 2025
- Website
- careaccesspbc.com/
- Ownership
- Privately Held (backing)
Care Access doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Care Access shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Care Access in its N-PORT filings yet. We sweep new filings monthly.